Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Preservation solution of time-resolved fluorescent microsphere labeled myoglobin antibody

A time-resolved fluorescence and myoglobin technology is applied in the field of time-resolved fluorescent microsphere-labeled myoglobin antibody preservation solutions, which can solve the problems of reagent detection risks, failure to see, and inability to perform detection.

Active Publication Date: 2017-06-20
佛山墨赛生物技术有限公司
View PDF7 Cites 10 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, the stability of the fluorescent microspheres plays a key role in the subsequent detection steps. If the fluorescent microspheres are improperly stored, subsequent detection will not be possible, affecting the performance of the final detection reagent and bringing serious risks to reagent detection.
[0004] The time-resolved fluorescent microsphere-labeled myoglobin antibody (hereinafter referred to as labeled antibody) preservation solution is very important to maintain the stability of the labeled antibody in the liquid and prevent it from precipitation. There is no report on the labeled antibody preservation solution.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Preservation solution of time-resolved fluorescent microsphere labeled myoglobin antibody
  • Preservation solution of time-resolved fluorescent microsphere labeled myoglobin antibody

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0026] A time-resolved fluorescent microsphere-labeled myoglobin antibody preservation solution is prepared by the following steps:

[0027] First weigh 1.5g of dextran, dissolve it in 500g of aqueous solution, stir at 60°C for 1h, then ultrasonically for 10min, after cooling to room temperature, weigh 6g of 4-hydroxyethylpiperazineethanesulfonic acid (HEPES), chlorine Sodium Chloride (NaCl) 10g, Potassium Chloride (KCL) 5g, Disodium Ethylenediaminetetraacetic Acid (EDTA-2Na) 0.9g, Sodium Dodecyl Sulfonate (SDS) 0.3g, Bovine Serum Albumin (BSA) 10g, Triton X-100 0.5g, Tween-200.2g, Procline 0.5g, water to make up to 1000g, mix well, adjust pH to 8.5, and obtain time-resolved fluorescent microsphere-labeled myoglobin antibody preservation solution.

Embodiment 2

[0029] A time-resolved fluorescent microsphere-labeled myoglobin antibody preservation solution is prepared by the following steps:

[0030] First weigh 1g of dextran, dissolve it in 500g of aqueous solution, stir at 60°C for 1h, then sonicate for 10min, after cooling to room temperature, weigh 8g of 4-hydroxyethylpiperazineethanesulfonic acid (HEPES), chlorinated Sodium (NaCl) 14g, potassium chloride (KCL) 5g, ethylenediaminetetraacetic acid disodium (EDTA-2Na) 0.8g, sodium dodecylsulfonate (SDS) 0.5g, bovine serum albumin (BSA) 15g , Triton X-100 0.8g, Tween-20 0.2g, Procline 0.5g, make up to 1000g with water, and mix well to obtain time-resolved fluorescent microsphere-labeled myoglobin antibody preservation solution.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a preservation solution of a time-resolved fluorescent microsphere labeled myoglobin antibody. The preservation solution is prepared from the following components in percentage by mass: 0.1 percent to 1.5 percent of 4-(2-hydroxyethyl)piperazine-1-erhanesulfonic acid, 1.0 percent to 3.0 percent of sodium chloride, 0.3 percent to 0.8 percent of potassium chloride, 0.08 percent to 0.9 percent of disodium ethylene diamine tetraacetate, 0.01 percent to 0.06 percent of sodium dodecyl sulfonate, 0.1 percent to 3.0 percent of bovine serum albumin, 0.05 percent to 0.5 percent of glucan, 0.02 percent to 0.2 percent of triton, 0.01 percent to 0.05 percent of Tween-20, 0.02 percent to 0.1 percent of a preservative and the balance of water; the pH (Potential of Hydrogen) is adjusted to be 8.0 to 9.0. The preservation solution has the advantages that the raw materials are low in cost and easy to obtain, and a relatively stable microenvironment is provided for preservation of fluorescent microspheres.

Description

technical field [0001] The invention relates to the technical field of biochemical preparations, in particular to a time-resolved fluorescent microsphere-labeled myoglobin antibody preservation solution. Background technique [0002] In acute myocardial injury, myoglobin (MYO) is first released into the blood, and 2-3 hours after the onset of symptoms, the blood myoglobin (MYO) can exceed the normal upper limit, and reach the peak at 9-12 hours, 24 - Recovery after 36 hours. Although positive MYO cannot confirm the diagnosis of AMI, it can be used as an important indicator to exclude the diagnosis of AMI in the early stage. If MYO is negative, myocardial infarction can be basically ruled out. For the accuracy and stability of the detection, the diluent of the labeled antibody used in the final test is a key step. [0003] Time-resolved fluorescence biochemical analysis technology is established based on the special fluorescence properties of rare earth fluorescent complexe...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): G01N33/533
CPCG01N33/533
Inventor 谭有将戴尽波陈静
Owner 佛山墨赛生物技术有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products